Clinical Trials Browser

OTHER_GOV × HMPL-013 × 1 year × Clear all

NCT05177068 2025-10-02

Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer

Phase 2 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT06329973 2025-07-17

Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer

Phase 1/2 Recruiting

Gastrointestinal

Metastatic Gastroesophageal Junction Adenocarcinoma